Matthew B. Harms

8.8k citations

33 papers · 3.2k indexed · 3 hit papers · h-index 24

Neurology top 0.5%
Molecular Biology top 5%
Genetics top 0.5%
Cellular and Molecular Neuroscience top 2%
Neurology top 1%

Co-authors: Robert H. Baloh Alan Pestronk Timothy M. Miller John Ravits Peggy Allred Shaughn Bell Craig M. Zaidman Jacqueline G. O’Rourke
Topics: Neurogenetic and Muscular Disorders Research (16 papers)Amyotrophic Lateral Sclerosis Research (16 papers)Genetic Neurodegenerative Diseases (6 papers)
Cited by: Neurology Genetics
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Australia Canada

In The Last Decade

Matthew B. Harms

31 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

2013 577 citations Timothy M. Miller, Matthew B. Harms et al. profile →
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

2013 493 citations Dhruv Sareen, Jacqueline G. O’Rourke et al. Science Translational Medicine profile →
C9orf72 is required for proper macrophage and microglial function in mice

2016 400 citations Jacqueline G. O’Rourke, Laurent Bogdanik et al. Science profile →

Peers

Countries citing papers authored by Matthew B. Harms

Since Specialization

Citations

This map shows the geographic impact of Matthew B. Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Harms more than expected).

Fields of papers citing papers by Matthew B. Harms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Harms. The network helps show where Matthew B. Harms may publish in the future.

Co-authorship network of co-authors of Matthew B. Harms

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Harms. A scholar is included among the top collaborators of Matthew B. Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Harms. Matthew B. Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives 2024 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ik Jae Lee,(unknown),Joanne Wuu,Elizabeth A. Harrington,James D. Berry,Timothy M. Miller,Matthew B. Harms,Michael Benatar,Neil A. Shneider	0
2	Evidence‐based consensus guidelines for ALS genetic testing and counseling 2023 ·Annals of Clinical and Translational Neurology ·Jennifer Roggenbuck,Breda Eubank,Joshua D. Wright,Matthew B. Harms,(unknown),(unknown)	24
3	Precision genetic cellular models identify therapies protective against ER stress 2021 ·Cell Death and Disease ·Irina V. Lebedeva,Michelle V. Wagner,Sunil Sahdeo,Yifan Lu,(unknown),Matthew B. Harms,Jehangir S. Wadia,G. Rajagopal,Michael J. Boland,David B. Goldstein	8
4	Primary lateral sclerosis: consensus diagnostic criteria 2020 ·Journal of Neurology Neurosurgery & Psychiatry ·Martin R. Turner,Richard J. Barohn,Philippe Corcia,John K. Fink,Matthew B. Harms,Matthew C. Kiernan,John Ravits,Vincenzo Silani,Zachary Simmons,Jeffrey Statland,Leonard H. van den Berg,Hiroshi Mitsumoto,(unknown)	125
5	A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS 2019 ·Genome Research ·Sahar Gelfman,Sarah A. Dugger,Cristiane Araújo Martins Moreno,Zhong Ren,Charles J. Wolock,Neil A. Shneider,Hemali Phatnani,Elizabeth T. Cirulli,Brittany N. Lasseigne,Tim Harris,Tom Maniatis,Guy A. Rouleau,Robert H. Brown,Aaron D. Gitler,R Myers,Slavé Petrovski,Andrew S. Allen,David B. Goldstein,Matthew B. Harms	14
6	Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy 2018 ·Neuromuscular Disorders ·Andrew R. Findlay,Matthew B. Harms,Alan Pestronk,Conrad C. Weihl	9
7	C9orf72 is required for proper macrophage and microglial function in micebreakdown → 2016 ·Science ·Jacqueline G. O’Rourke,Laurent Bogdanik,Alberto Yáñez,Deepti Lall,Andrea J. Wolf,A.K.M. Ghulam Muhammad,Ritchie Ho,Sharon Carmona,Jean‐Philippe Vit,Jonah E. Zarrow,(unknown),Shaughn Bell,Matthew B. Harms,Timothy M. Miller,Charles A. Dangler,David M. Underhill,Helen S. Goodridge,Cathleen Lutz,Robert H. Baloh	400
8	Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis 2015 ·Neuromuscular Disorders ·Conrad C. Weihl,Robert H. Baloh,Youjin Lee,Tsui‐Fen Chou,Sara K. Pittman,Glenn Lopate,Peggy Allred,Jennifer Jockel‐Balsarotti,Alan Pestronk,Matthew B. Harms	49
9	LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tongues 2015 ·Clinical Genetics ·Jodi Warman‐Chardon,Amanda Smith,John Woulfe,Elena Peña,Kawan Rakhra,Carole Dennie,Chandree L. Beaulieu,Lijia Huang,Jeremy Schwartzentruber,Cynthia Hawkins,Matthew B. Harms,(unknown),(unknown),Jacek Majewski,Dennis E. Bulman,Kym M. Boycott,David A. Dyment	15
10	Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1 2015 ·Journal of Neurology ·Alleene V. Strickland,Maria Schabhüttl,H. Offenbacher,Matthis Synofzik,Natalie Hauser,Michaela Brunner‐Krainz,U Gruber‐Sedlmayr,Steven A. Moore,Reinhard Windhager,Benjamin Bender,Matthew B. Harms,Stephan Klebe,Peter Young,Marina Kennerson,(unknown),Michael Gonzalez,Stephan Züchner,Rebecca Schüle,Michael E. Shy,Michaela Auer‐Grumbach	49
11	Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier 2014 ·Acta Neuropathologica ·Jenny Russ,(unknown),Kathryn Wu,Donald Neal,EunRan Suh,David J. Irwin,Corey T. McMillan,Matthew B. Harms,Nigel J. Cairns,Elisabeth McCarty Wood,Sharon X. Xie,Lauren Elman,Leo McCluskey,Murray Grossman,Vivianna M. Van Deerlin,Edward B. Lee	90
12	Autophagic vacuolar pathology in desminopathies 2014 ·Neuromuscular Disorders ·Conrad C. Weihl,Stanley Iyadurai,Robert H. Baloh,Sara K. Pittman,Robert E. Schmidt,Glenn Lopate,Alan Pestronk,Matthew B. Harms	20
13	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis 2014 ·Human Molecular Genetics ·Jillian G. Buchan,David M. Alvarado,Gabe Haller,Carlos Cruchaga,Matthew B. Harms,Tianxiao Zhang,Marcia Willing,Dorothy K. Grange,Alan C. Braverman,Nancy H. Miller,José A. Morcuende,Nelson L.S. Tang,Tsz Ping Lam,Bobby K. W. Ng,Jack C. Y. Cheng,Matthew B. Dobbs,Christina A. Gurnett	83
14	Ultrasound of inherited vs. acquired demyelinating polyneuropathies 2013 ·Journal of Neurology ·Craig M. Zaidman,Matthew B. Harms,Alan Pestronk	112
15	Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age 2013 ·Neurobiology of Disease ·Judith Eschbach,Jérôme Sinniger,Jamal Bouitbir,Anissa Fergani,Anna-Isabel Schlagowski,Joffrey Zoll,Bernard Gény,Frédérique René,Yves Larmet,Vincent Marion,Robert H. Baloh,Matthew B. Harms,Michael E. Shy,(unknown),Patrick Weydt,Jean‐Philippe Loeffler,Albert C. Ludolph,Luc Dupuis	41
16	Clinical Neurogenetics 2013 ·Neurologic Clinics ·Matthew B. Harms,Robert H. Baloh	24
17	Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansionbreakdown → 2013 ·Science Translational Medicine ·Dhruv Sareen,Jacqueline G. O’Rourke,Pratap Meera,A.K.M. Ghulam Muhammad,(unknown),Megan Simpkinson,Shaughn Bell,Sharon Carmona,Loren Ornelas,Anais Sahabian,Tania F. Gendron,Leonard Petrucelli,Michael W. Baughn,John Ravits,Matthew B. Harms,Frank Rigo,C. Frank Bennett,Thomas S. Otis,Clive N. Svendsen,Robert H. Baloh	493
18	Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis 2013 ·Neurobiology of Aging ·Matthew B. Harms,Janet Cady,Craig M. Zaidman,Paul Cooper,Taha Bali,Peggy Allred,Carlos Cruchaga,Michael W. Baughn,(unknown),Alan Pestronk,Alison Goate,John Ravits,Robert H. Baloh	58
19	Parkinson disease is not associated with C9ORF72 repeat expansions 2012 ·Neurobiology of Aging ·Matthew B. Harms,Drexel A. Neumann,Bruno A. Benítez,Breanna Cooper,David Carrell,Brad A. Racette,Joel S. Perlmutter,Alison Goate,Carlos Cruchaga	33
20	Exome sequencing reveals DNAJB6 mutations in dominantly‐inherited myopathy 2011 ·Annals of Neurology ·Matthew B. Harms,R. Brian Sommerville,Peggy Allred,Shaughn Bell,Duanduan Ma,Paul R. Cooper,Glenn Lopate,Alan Pestronk,Conrad C. Weihl,Robert H. Baloh	124

About Matthew B. Harms

Matthew B. Harms is a scholar working on Genetics, Neurology and Neurology, having authored 33 papers that have together received 3.2k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (16 papers), Amyotrophic Lateral Sclerosis Research (16 papers) and Genetic Neurodegenerative Diseases (6 papers). The work is most often cited by research in Neurology (1.8k citations), Genetics (1.1k citations) and Neurology (611 citations). Matthew B. Harms has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Robert H. Baloh, Alan Pestronk, Timothy M. Miller, John Ravits, Peggy Allred, Shaughn Bell, Craig M. Zaidman, Jacqueline G. O’Rourke, Sharon Carmona and A.K.M. Ghulam Muhammad. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact